{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:04:26Z","timestamp":1761332666282,"version":"build-2065373602"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Backgroud and Objective: Antithyroid drugs (ATDs) [methylmercaptoimidazole (MMI) and\npropylthiouracil (PTU) ] are used to treat hyperthyroidism in Graves\u2019 disease. The effect of ATDs and\nreducing agents (mercaptoethanol, dithiothreitol and cysteine) on bovine (b) TSH binding to human (h)\nand porcine (p) TSH receptor (R) was examined.<\/jats:p>\n                    <jats:p>Methods and Results: (1) ATDs was pre-incubated with hTSHR coated tube for 1- 4 h, washed free of\nATDs, and then 125I-bTSH binding to hTSHR after 1 h incubation was examined. MMI (10\u201340 mM)\ndecreased 125I-bTSH binding in a dose-dependent manner and binding decreased proportionally as preincubation\ntime increased from 1 to 4 h. PTU (10mM) slightly decreased binding, When reducing\nagents were pre-incubated with hTSHR for 2 h, 125I-bTSH binding similarly decreased. (2) Porcine thyroid\nmembrane was pre-incubated with both agents for 2 h. Then, the washed or unwashed membrane\nwas incubated with 125I-bTSH for 1 h. 125I-bTSH binding in both methods decreased. (3) When the effect\nof ATDs or reducing agents on the biological activity of 125I-bTSH and thyroid stimulating antibody\n(TSAb) was examined after gel-filtration of 125I-bTSH- and TSAb- treated with both reagents for 1 h, no\ninactivation was observed. (4) ATDs showed similar reducing action as reducing agents because iodine\n(I+) was reduced to I- by ATDs.<\/jats:p>\n                    <jats:p>Conclusion: ATDs inactivate the TSH-binding site of TSHR by reduction, although ATDs do not inactivate\nbTSH and TSAb activity. This suggests that TSAb would not stimulate the thyroid due to the\ninactivation of the TSHR when ATDs are administered to patients with Graves\u2019 disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1871530318666180220101845","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T10:42:54Z","timestamp":1519123374000},"page":"508-512","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antithyroid Drugs Inactivate TSH Binding to the TSH Receptor by their Reducing Action"],"prefix":"10.2174","volume":"18","author":[{"given":"Yukio","family":"Ochi","sequence":"first","affiliation":[{"name":"Research Institute for Production Development, Kyoto 606-0805,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hachiya","sequence":"additional","affiliation":[{"name":"Midorigaoka Hospital, Takatsuki, Osaka 569-1121,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Koyama","sequence":"additional","affiliation":[{"name":"Radioisotope Research Center, Shiga University of Medical Science, Otsu, Shiga 520-2192,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutoshi","family":"Fukuhori","sequence":"additional","affiliation":[{"name":"Radioisotope Research Center, Shiga University of Medical Science, Otsu, Shiga 520-2192,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Ashida","sequence":"additional","affiliation":[{"name":"Yamasa Ltd, Choshi, Chiba 288-0056,Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530318666180220101845","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/159945\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530318666180220101845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:01:06Z","timestamp":1761332466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/159945\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530318666180220101845","relation":{},"ISSN":["1871-5303"],"issn-type":[{"type":"print","value":"1871-5303"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-09-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}